Five-year outcomes comparing medical management and microvascular decompression in trigeminal neuralgia
Despite how common GLP-1 use has become, there has been relatively little dermatology-focused research on their cutaneous side effects, with most of the existing literature limited to individual case reports. For the cross-sectional analysis, Fat and colleagues compared cutaneous adverse events reported in the FDA Adverse Event Reporting System (FAERS) for the GLP-1 receptor agonists semaglutide (Ozempic/ Wegovy, Novo Nordisk), liraglutide, exenatide and dulaglutide (Trulicity, Eli Lilly) with cutaneous adverse event reports for the dipeptidyl peptidase-4 (DPP-IV) inhibitors sitagliptin, saxagliptin, linagliptin and alogliptin
We reveal how powerful counterfeit weight loss jabs including a fake version of a new product, still in development and not yet approved for human use are being sold online and injected without medical oversight
Ozempic quiets those signals, which can help you lose weight and not regain it
Craig Jonov, is a premier cosmetic surgery practice serving patients in Bellevue, Kirkland, and beyond
Cost sensitivity points toward injection